REVOLUTION MEDICINES INC (RVMD) Stock Analyst Ratings
USA - NASDAQ:RVMD - US76155X1000 - Common Stock
46.55 USD
+0.31 (+0.67%)
46.98 USD
+0.43 (+0.92%)
ChartMill assigns a Buy % Consensus number of 86% to RVMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 74.02. This target is 59.02% above the current price.
RVMD was analyzed by 22 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about RVMD.
In the previous month the buy percentage consensus was at a similar level.
RVMD was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-12 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-09-11 | Needham | Maintains | Buy -> Buy |
| 2025-09-11 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-05 | Truist Securities | Initiate | Buy |
| 2025-08-19 | Piper Sandler | Initiate | Overweight |
| 2025-08-18 | LifeSci Capital | Initiate | Outperform |
| 2025-08-15 | Wells Fargo | Initiate | Overweight |
| 2025-08-07 | Needham | Maintains | Buy -> Buy |
| 2025-07-15 | Goldman Sachs | Initiate | Buy |
| 2025-06-25 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-06-24 | Needham | Reiterate | Buy -> Buy |
| 2025-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-08 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-08 | Needham | Reiterate | Buy -> Buy |
| 2025-05-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-28 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-04-01 | Stifel | Maintains | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-27 | Needham | Maintains | Buy -> Buy |
| 2025-02-27 | Stifel | Maintains | Buy -> Buy |
| 2025-01-08 | UBS | Maintains | Buy -> Buy |
| 2024-12-06 | Needham | Maintains | Buy -> Buy |
| 2024-12-06 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-12-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-03 | Guggenheim | Maintains | Buy -> Buy |
| 2024-12-03 | Needham | Reiterate | Buy -> Buy |
| 2024-12-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-07 | Needham | Maintains | Buy -> Buy |